{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:41:29Z","timestamp":1790138489197,"version":"4.0.1"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.02291","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:40:02Z","timestamp":1537850402000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic Targets in Chlamydial Fatty Acid and Phospholipid Synthesis"],"prefix":"10.3389","volume":"9","author":[{"given":"Jiangwei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles O.","family":"Rock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.femsre.2005.03.002","article-title":"The chlamydial developmental cycle.","volume":"29","author":"Abdelrahman","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1128\/IAI.01530-14","article-title":"Expression of the effector protein IncD in Chlamydia trachomatis mediates recruitment of the lipid transfer protein CERT and the endoplasmic reticulum-resident protein VAPB to the inclusion membrane.","volume":"82","author":"Agaisse","year":"2014","journal-title":"Infect. Immun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/mmi.12829","article-title":"Chlamydia trachomatis remodels stable microtubules to coordinate Golgi stack recruitment to the chlamydial inclusion surface.","volume":"94","author":"Al-Zeer","year":"2014","journal-title":"Mol. Microbiol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a010256","article-title":"Chlamydial intracellular survival strategies.","volume":"3","author":"Bastidas","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1128\/IAI.00129-08","article-title":"Late endocytic multivesicular bodies intersect the chlamydial inclusion in the absence of CD63.","volume":"76","author":"Beatty","year":"2008","journal-title":"Infect. Immun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrmicro931","article-title":"Focus: chlamydia.","volume":"2","author":"Belland","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/Bf00404752","article-title":"Fatty acid profiles of Chlamydia using capillary gas chromatography.","volume":"55","author":"Bidawid","year":"1989","journal-title":"Antonie Van Leeuwenhoek"},{"key":"B8","doi-asserted-by":"crossref","first-page":"25513","DOI":"10.1016\/S0021-9258(19)74070-8","article-title":"Cloning, sequencing, and expression of the fadD gene of Escherichia coli encoding acyl coenzyme A synthetase.","volume":"267","author":"Black","year":"1992","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrmicro2245","article-title":"What are the consequences of the disappearing human microbiota?","volume":"7","author":"Blaser","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/infdis\/111.2.117","article-title":"Enhanced susceptibility to Salmonella infection in streptomycin-treated mice.","volume":"111","author":"Bohnhoff","year":"1962","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086196","article-title":"The intracellular bacteria Chlamydia hijack peroxisomes and utilize their enzymatic capacity to produce bacteria-specific phospholipids.","volume":"9","author":"Boncompain","year":"2014","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1530\/EJE-14-1163","article-title":"The effect of past antibiotic exposure on diabetes risk.","volume":"172","author":"Boursi","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1128\/JB.01240-07","article-title":"Competitive inhibition of amino acid uptake suppresses Chlamydial growth: involvement of the Chlamydial amino acid transporter BrnQ.","volume":"190","author":"Braun","year":"2008","journal-title":"J. Bacteriol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.05496-11","article-title":"Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.","volume":"80","author":"Buffie","year":"2012","journal-title":"Infect. Immun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1073\/pnas.1131289100","article-title":"Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion.","volume":"100","author":"Carabeo","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nature11400","article-title":"Antibiotics in early life alter the murine colonic microbiome and adiposity.","volume":"488","author":"Cho","year":"2012","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9379","DOI":"10.1073\/pnas.0712241105","article-title":"Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole.","volume":"105","author":"Cocchiaro","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1016\/S0021-9258(18)83245-8","article-title":"2-Acylglycerolphosphoethanolamine acyltransferase\/acyl-acyl carrier protein synthetase is a membrane-associated acyl carrier protein binding protein.","volume":"264","author":"Cooper","year":"1989","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/cmi.12523","article-title":"Chlamydia trachomatis utilizes the mammalian CLA1 lipid transporter to acquire host phosphatidylcholine essential for growth.","volume":"18","author":"Cox","year":"2016","journal-title":"Cell. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1462-5822.2012.01823.x","article-title":"Host HDL biogenesis machinery is recruited to the inclusion of Chlamydia trachomatis-infected cells and regulates chlamydial growth.","volume":"14","author":"Cox","year":"2012","journal-title":"Cell. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0076-6879(97)80104-8","article-title":"Phosphatidylserine decarboxylases: pyruvoyl-dependent enzymes from bacteria to mammals.","volume":"280","author":"Dowhan","year":"1997","journal-title":"Method Enzymol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1462-5822.2012.01794.x","article-title":"Lipid acquisition by intracellular Chlamydiae.","volume":"14","author":"Elwell","year":"2012","journal-title":"Cell. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002198","article-title":"Chlamydia trachomatis co-opts GBF1 and CERT to acquire host sphingomyelin for distinct roles during intracellular development.","volume":"7","author":"Elwell","year":"2011","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1128\/jb.176.19.6082-6087.1994","article-title":"Characterization of lipoprotein EnvA in Chlamydia psittaci 6BC.","volume":"176","author":"Everett","year":"1994","journal-title":"J. Bacteriol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1128\/AAC.05119-14","article-title":"Activity of debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.","volume":"59","author":"Flamm","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02515-16","article-title":"Clinical relevance of type II fatty acid synthesis bypass in Staphylococcus aureus.","volume":"61","author":"Gloux","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1073\/pnas.92.11.4877","article-title":"Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion.","volume":"92","author":"Hackstadt","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1128\/Aac.01741-15","article-title":"Efficacy and safety of AFN-1252, the first Staphylococcus-specific antibacterial agent, in the treatment of acute bacterial skin and skin structure infections, including those in patients with significant comorbidities.","volume":"60","author":"Hafkin","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/JB.150.2.662-670.1982","article-title":"Adenine nucleotide and lysine transport in Chlamydia psittaci.","volume":"150","author":"Hatch","year":"1982","journal-title":"J. Bacteriol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"26538","DOI":"10.1074\/jbc.270.44.26538","article-title":"Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.","volume":"270","author":"Heath","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/35018162","article-title":"A triclosan-resistant bacterial enzyme.","volume":"406","author":"Heath","year":"2000","journal-title":"Nature (London)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/0968051907079122","article-title":"Investigation on the agonistic and antagonistic biological activities of synthetic Chlamydia lipid A and its use in in vitro enzymatic assays.","volume":"13","author":"Heine","year":"2007","journal-title":"J. Endotoxin. Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1046\/j.1432-1033.2003.03392.x","article-title":"Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC.","volume":"270","author":"Heine","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"B34","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1016\/S0021-9258(18)92769-9","article-title":"Isolation and characterization of Escherichia coli K-12 mutants lacking both 2-acyl-glycerophosphoethanolamine acyltransferase and acyl-acyl carrier protein synthetase activity.","volume":"266","author":"Hsu","year":"1991","journal-title":"J. Biol. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1179\/1973947815Y.0000000075","article-title":"Safety, tolerability and pharmacokinetics of multiple oral doses of AFN-1252 administered as immediate release (IR) tablets in healthy subjects.","volume":"28","author":"Hunt","year":"2015","journal-title":"J. Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2958.1999.01464.x","article-title":"Glucose metabolism in Chlamydia trachomatis: the \u2018energy parasite\u2019 hypothesis revisited.","volume":"33","author":"Iliffe-Lee","year":"1999","journal-title":"Mol. Microbiol."},{"key":"B37","doi-asserted-by":"crossref","first-page":"11328","DOI":"10.1016\/S0021-9258(18)67387-9","article-title":"Transfer of fatty acids from the 1-position of phosphatidylethanolamine to the major outer membrane lipoprotein of Escherichia coli.","volume":"261","author":"Jackowski","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"10008","DOI":"10.1021\/bi060842w","article-title":"The soluble acyl-acyl carrier protein synthetase of Vibrio harveyi B392 is a member of the medium chain acyl-CoA synthetase family.","volume":"45","author":"Jiang","year":"2006","journal-title":"Biochemistry"},{"key":"B39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1021\/bi901890a","article-title":"Expression of Vibrio harveyi acyl-ACP synthetase allows efficient entry of exogenous fatty acids into the Escherichia coli fatty acid and lipid A synthetic pathways.","volume":"49","author":"Jiang","year":"2010","journal-title":"Biochemistry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"5865","DOI":"10.1128\/AAC.01411-12","article-title":"Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor.","volume":"56","author":"Kaplan","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ejps.2013.08.019","article-title":"AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects.","volume":"50","author":"Kaplan","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"B42","doi-asserted-by":"crossref","first-page":"10856","DOI":"10.1016\/S0021-9258(17)44354-7","article-title":"The DNA sequences encoding plsB and dgk loci of Escherichia coli.","volume":"258","author":"Lightner","year":"1983","journal-title":"J. Biol. Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.molcel.2006.06.030","article-title":"Acyl-phosphates initiate membrane phospholipid synthesis in gram-positive pathogens.","volume":"23","author":"Lu","year":"2006","journal-title":"Mol. Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1042\/BJ20021699","article-title":"Characterization of Streptococcus pneumoniae enoyl-[acyl carrier protein] reductase (FabK).","volume":"370","author":"Marrakchi","year":"2003","journal-title":"Biochem. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.tet.2015.09.069","article-title":"Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics.","volume":"72","author":"Maxson","year":"2016","journal-title":"Tetrahedron"},{"key":"B46","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1469-0691.12172","article-title":"Gut bacterial microbiota and obesity.","volume":"19","author":"Million","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"B47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.chom.2015.06.004","article-title":"Global mapping of the inc-human interactome reveals that retromer restricts Chlamydia infection.","volume":"18","author":"Mirrashidi","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063426","article-title":"Role for chlamydial inclusion membrane proteins in inclusion membrane structure and biogenesis.","volume":"8","author":"Mital","year":"2013","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1172\/JCI72333","article-title":"Antibiotics and the gut microbiota.","volume":"124","author":"Modi","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12944","article-title":"Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials.","volume":"7","author":"Morvan","year":"2016","journal-title":"Nat. Commun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biochi.2017.07.004","article-title":"The Staphylococcus aureus FASII bypass escape route from FASII inhibitors.","volume":"141","author":"Morvan","year":"2017","journal-title":"Biochimie"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1128\/JB.01889-06","article-title":"Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein.","volume":"189","author":"Neff","year":"2007","journal-title":"J. Bacteriol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/1574-6976.12059","article-title":"Chlamydial metabolism revisited: interspecies metabolic variability and developmental stage-specific physiologic activities.","volume":"38","author":"Omsland","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06862-0","article-title":"Changes in the intestinal microbiota following the administration of azithromycin in a randomised placebo-controlled trial among infants in south India.","volume":"7","author":"Parker","year":"2017","journal-title":"Sci. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10532","DOI":"10.1073\/pnas.1408797111","article-title":"Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus.","volume":"111","author":"Parsons","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B56","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1128\/AAC.01038-13","article-title":"Staphylococcus aureus fatty acid auxotrophs do not proliferate in mice.","volume":"57","author":"Parsons","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"15378","DOI":"10.1073\/pnas.1109208108","article-title":"Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors.","volume":"108","author":"Parsons","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.plipres.2013.02.002","article-title":"Bacterial lipids: metabolism and membrane homeostasis.","volume":"52","author":"Parsons","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery.","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B60","doi-asserted-by":"publisher","first-page":"l743","DOI":"10.1021\/bi00537a007","article-title":"Acyl and phosphoryl migration in lysophospholipids: importance in phospholipid synthesis and phospholipase specificity.","volume":"21","author":"Pluckthun","year":"1982","journal-title":"Biochemistry"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/srep23148","article-title":"Chlamydia trachomatis growth and development requires the activity of host Long-chain Acyl-CoA Synthetases (ACSLs).","volume":"6","author":"Recuero-Checa","year":"2016","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nsmb.3436","article-title":"A two-helix motif positions the lysophosphatidic acid acyltransferase active site for catalysis within the membrane bilayer.","volume":"24","author":"Robertson","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B63","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/S0021-9258(18)50292-1","article-title":"Solubilization, purification, and salt activation of acyl-acyl carrier protein synthetase from Escherichia coli.","volume":"254","author":"Rock","year":"1979","journal-title":"J. Biol. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"16819","DOI":"10.1074\/jbc.274.24.16819","article-title":"Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2.","volume":"274","author":"Rund","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124630","article-title":"Chlamydia trachomatis infection leads to defined alterations to the lipid droplet proteome in epithelial cells.","volume":"10","author":"Saka","year":"2015","journal-title":"PLoS One"},{"key":"B66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd2202","article-title":"Multi-targeting by monotherapeutic antibacterials.","volume":"6","author":"Silver","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery.","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16116-8","article-title":"Phosphatidylserine decarboxylase CT699, lysophospholipid acyltransferase CT775, and acyl-ACP synthase CT776 provide membrane lipid diversity to Chlamydia trachomatis.","volume":"7","author":"Soupene","year":"2017","journal-title":"Sci. Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mbo3.234","article-title":"Remodeling of host phosphatidylcholine by Chlamydia acyltransferase is regulated by acyl-CoA binding protein ACBD6 associated with lipid droplets.","volume":"4","author":"Soupene","year":"2015","journal-title":"MicrobiologyOpen"},{"key":"B70","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature22972","article-title":"Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.","volume":"546","author":"Spaulding","year":"2017","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis.","volume":"282","author":"Stephens","year":"1998","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"9409","DOI":"10.1074\/jbc.M312008200","article-title":"Activation of Raf\/MEK\/ERK\/cPLA2 signaling pathway is essential for chlamydial acquisition of host glycerophospholipids.","volume":"279","author":"Su","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0969-2126(01)00595-0","article-title":"Analysis of the structure, substrate specificity, and mechanism of squash glycerol-3-phosphate (1)-acyltransferase.","volume":"9","author":"Turnbull","year":"2001","journal-title":"Structure"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.celrep.2017.04.058","article-title":"Absence of specific Chlamydia trachomatis inclusion membrane proteins triggers premature inclusion membrane lysis and host cell death.","volume":"19","author":"Weber","year":"2017","journal-title":"Cell Rep."},{"key":"B75","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1128\/jb.179.23.7233-7242.1997","article-title":"Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis.","volume":"179","author":"Wylie","year":"1997","journal-title":"J. Bacteriol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"22365","DOI":"10.1074\/jbc.M114.584185","article-title":"Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.","volume":"289","author":"Yao","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1074\/jbc.M115.699462","article-title":"Activation of exogenous fatty acids to acyl-acyl carrier protein cannot bypass FabI inhibition in Neisseria.","volume":"291","author":"Yao","year":"","journal-title":"J. Biol. Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1128\/AAC.00535-16","article-title":"A pathogen-selective antibiotic minimizes disturbance to the microbiome.","volume":"60","author":"Yao","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"18874","DOI":"10.1074\/jbc.M115.657148","article-title":"Chlamydia trachomatis relies on autonomous phospholipid synthesis for membrane biogenesis.","volume":"290","author":"Yao","year":"","journal-title":"J. Biol. Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"22163","DOI":"10.1074\/jbc.M115.671008","article-title":"Chlamydia trachomatis scavenges host fatty acids for phospholipid synthesis via an acyl-acyl carrier protein synthetase.","volume":"290","author":"Yao","year":"","journal-title":"J. Biol. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"36261","DOI":"10.1074\/jbc.M113.512905","article-title":"Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).","volume":"288","author":"Yao","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B82","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bbalip.2012.08.018","article-title":"Phosphatidic acid synthesis in bacteria.","volume":"1831","author":"Yao","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B83","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1074\/jbc.R114.636241","article-title":"How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.","volume":"290","author":"Yao","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027045","article-title":"Resistance mechanisms and the future of bacterial enoyl-acyl carrier protein reductase (FabI) antibiotics.","volume":"6","author":"Yao","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.bbalip.2016.09.014","article-title":"Bacterial fatty acid metabolism in modern antibiotic discovery.","volume":"1862","author":"Yao","year":"","journal-title":"Biochim. Biophys. Acta"},{"key":"B86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biochi.2017.06.015","article-title":"Exogenous fatty acid metabolism in bacteria.","volume":"141","author":"Yao","year":"","journal-title":"Biochimie"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02291\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:57:30Z","timestamp":1662137850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02291\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":86,"alternative-id":["10.3389\/fmicb.2018.02291"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.02291","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,25]]},"article-number":"2291"}}